Abstract
Prescription opioids have resulted in large part to a substance use disorder (SUD) epidemic. Relapse rates for patients with SUD within 30 days of leaving an inpatient drug and alcohol treatment center are reported at 40-60%. When determining which therapy (e.g., opioids v. neuromodulation) is ideal for a person with chronic pain, understanding the factors that lead to treatment refractory SUD is essential. We aim to show proof of principle for machine learning (ML) and predictive analytics on short-term success or failure with SUD treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
